Retrospective Analysis Based on Clinical Experience of Tapentadol in Cancer Pain Management
Palliative Care Research
;
: 306-310, 2016.
Artigo
em Japonês
| WPRIM
| ID: wpr-377256
ABSTRACT
Objective:
To examine the clinical significance of an opioid, tapentadol, for cancer pain relief including its analgesic effects and indications based on our clinical experience.Methods:
We retrospectively studied 31 patients receiving tapentadol in our hospital.Results:
In 19 successfully treated patients, the numerical rating scale (NRS) scores showed a significant decrease in pain, and the doses at the start and completion of administration were 73.7±25.6 mg (morphine equivalent dose 30 mg or less) and 125±49.3 mg, respectively. Six successfully treated patients showed improvement of gastrointestinal symptoms. The results of the comparison between successfully and unsuccessfully treated patients suggested titration to be difficult in patients with mixture of somatic pain and neuropathic pain.Conclusion:
Based on our clinical experience, we consider tapentadol to be easy to use during the introductory period after treatment with non-opioids or low-dose opioids.
Buscar no Google
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Japonês
Revista:
Palliative Care Research
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS